What is First-Pass Hepatic Extraction?
First-pass hepatic extraction refers to the process where a drug, after oral administration, enters the systemic circulation via the portal vein and gets metabolized in the liver before reaching other parts of the body. This initial phase can significantly reduce the amount of active drug that reaches its target site.
The first-pass hepatic extraction ratio is a measure of this reduction, expressed as a percentage of the total dose that is extracted by the liver.
How Does It Work?
When an orally administered drug enters the gastrointestinal tract, it is absorbed into the bloodstream through the portal vein. As the blood passes through the liver, enzymes in the hepatic microsomes (primarily CYP450 enzymes) metabolize the drug, reducing its concentration before it can reach systemic circulation.
The efficiency of this process depends on several factors including the drug’s lipophilicity, first-pass metabolism rate, and the presence of other drugs that may induce or inhibit hepatic enzymes.
Why Does It Matter?
Understanding first-pass hepatic extraction is crucial for predicting a drug's bioavailability and efficacy. A high extraction ratio can lead to lower systemic concentrations, potentially reducing the therapeutic effect of the drug.
Conversely, drugs with low extraction ratios may have higher systemic levels, increasing the risk of toxicity.
Real-World Examples
For instance, caffeine is extensively metabolized in the liver, leading to a significant first-pass effect. Only about 10% of an oral dose reaches the systemic circulation.
In contrast, drugs like morphine have low hepatic extraction and are often administered parenterally to avoid this initial metabolic reduction.
Frequently asked questions
How does first-pass hepatic extraction affect drug dosing?
It can significantly impact the required dose. Drugs with high first-pass extraction may require higher oral doses compared to those with low extraction, as more of the administered dose is metabolized in the liver.
Can drugs be designed to avoid first-pass hepatic metabolism?
Yes, by formulating drugs for parenteral administration or using prodrugs that are activated after hepatic metabolism, it's possible to bypass this initial phase and achieve higher systemic concentrations.
What role do CYP450 enzymes play in first-pass extraction?
CYP450 enzymes are the primary metabolic pathway for many drugs. They catalyze the oxidation of drug molecules, reducing their bioavailability and potentially leading to toxic metabolites.
How can one determine the first-pass hepatic extraction ratio experimentally?
This is typically done by comparing the area under the curve (AUC) of a drug administered orally with that given intravenously. The difference in AUCs gives an estimate of the extent of first-pass metabolism.
Try it live
Everything above runs in your browser — open First-Pass Hepatic Extraction Ratio Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.
▶ Open First-Pass Hepatic Extraction Ratio Simulator simulation